Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H WEXLER

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Cancer|August 15, 1996
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid TumorsMelinda S Merchant, Matthew Wright, Kristin Baird, et al.
Blood|May 15, 1997
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapyC L Mackall, T A Fleisher, M R Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult CounterpartsCarla Saoud, Gunes Gundem, Chad M Vanderbilt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNAPeter Anderson, Maurizio Ghisoli, Brian D Crompton, et al.
Blood|October 1, 1994
Lymphocyte depletion during treatment with intensive chemotherapy for cancerC L Mackall, T A Fleisher, M R Brown, et al.
NPJ Precision Oncology|May 7, 2025
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomasCarla Saoud, Josephine K Dermawan, Kanika Arora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomasJ F Kuttesch, L H Wexler, R B Marcus, et al.
Genes, Chromosomes & Cancer|March 7, 2013
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcomaJuan Miguel Mosquera, Andrea Sboner, Lei Zhang, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Cancer|August 15, 1996
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid TumorsMelinda S Merchant, Matthew Wright, Kristin Baird, et al.
Blood|May 15, 1997
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapyC L Mackall, T A Fleisher, M R Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult CounterpartsCarla Saoud, Gunes Gundem, Chad M Vanderbilt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNAPeter Anderson, Maurizio Ghisoli, Brian D Crompton, et al.
Blood|October 1, 1994
Lymphocyte depletion during treatment with intensive chemotherapy for cancerC L Mackall, T A Fleisher, M R Brown, et al.
NPJ Precision Oncology|May 7, 2025
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomasCarla Saoud, Josephine K Dermawan, Kanika Arora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomasJ F Kuttesch, L H Wexler, R B Marcus, et al.
Genes, Chromosomes & Cancer|March 7, 2013
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcomaJuan Miguel Mosquera, Andrea Sboner, Lei Zhang, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Pageof 18